Cardiocast

Forget what you learned about infective endocarditis

Publish date: March 7, 2019

 

This week in MDedge Cardiocast: Infective endocarditis isn’t what it used to be, there’s a new, lower goal for Americans’ dietary intake of sodium, a drug to treat multiple myeloma also raises heart failure risk, and Big Pharma says it can’t drop drug list prices alone.
Amazon Alexa
Apple Podcasts
Google Podcasts
TuneIn

Recommended Reading

Atrial fib guidelines updated, SPRINT MIND published, and more
MDedge Cardiology
Immunotherapy’s cardiac effects require early monitoring, management
MDedge Cardiology
Impella RP shows higher mortality in postapproval study
MDedge Cardiology
Therapy ups breast cancer survivors’ cardiac risks
MDedge Cardiology
SGLT2 inhibitors morph into HF drugs
MDedge Cardiology
­­ADT harms likely limited to men with CV comorbidities
MDedge Cardiology
What comes first with SGLT2 inhibitors – diabetes or heart failure?
MDedge Cardiology
Heart failure outcomes are worse in select HIV-infected individuals
MDedge Cardiology
Commentary: Should AVFs be ligated after kidney transplant?
MDedge Cardiology
Infective endocarditis isn’t what it used to be
MDedge Cardiology